Skip to main content
Karo Pharma AB logo

Karo Pharma AB — Investor Relations & Filings

Ticker · KARO ISIN · SE0007464888 LEI · 213800G54Z51LOPGTA79 ST Manufacturing
Open in API
Filings indexed 653 across all filing types
Latest filing 2018-06-18 Transaction in Own Shar…
Country SE Sweden
Listing ST KARO

About Karo Pharma AB

https://www.karohealthcare.com/

Karo Pharma AB, operating as Karo Healthcare, is a healthcare company that develops, markets, and sells a broad portfolio of everyday healthcare products. The company's offerings are designed to prevent illness and treat common health problems, empowering consumers to manage their daily well-being. The portfolio consists of various branded medicines and consumer healthcare products distributed through pharmacies and directly to healthcare providers. With products available in over 90 countries, the company focuses on becoming a leading force in its sector by employing a consumer-centric approach, strategic innovation, and omnichannel excellence.

Recent filings

Filing Released Lang Actions
KARO PHARMAS STYRELSE HAR BESLUTAT OM FÖRVÄRV AV EGNA AKTIER
Transaction in Own Shares Classification · 99% confidence The document text is a press release dated June 18, 2018, announcing that the Board of Directors of Karo Pharma AB has decided on the repurchase of its own shares ('förvärv av egna aktier' / 'återköpsprogram'). This action directly relates to the company buying back its own stock. According to the definitions, 'Transaction in Own Shares (Code: POS)' covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. Although it is a short announcement, the core subject is the transaction itself, not just the announcement of a report, making POS a more specific fit than RPA or RNS. The document explicitly states the maximum value (86.3 MSEK) and number of shares to be repurchased.
2018-06-18 Swedish
KARO PHARMA´S BOARD OF DIRECTORS HAS RESOLVED TO REPURCHASE OWN SHARES
Transaction in Own Shares Classification · 99% confidence The document explicitly states in the headline and body that the Board of Directors has resolved to 'repurchase own shares' up to a maximum value of SEK 86.3 million. This action directly corresponds to the definition of a company buying back its own stock. The filing type code 'POS' (Transaction in Own Shares) is the most accurate classification for a share repurchase announcement.
2018-06-18 English
KARO PHARMA’S RIGHTS ISSUE FULLY SUBSCRIBED
Share Issue/Capital Change Classification · 99% confidence The document is a press release announcing that Karo Pharma's rights issue, which concluded on May 29, 2018, was fully subscribed. It details the subscription percentages, the amount of capital raised (SEK 1,315m), the resulting increase in share capital and the total number of shares. This content directly relates to fundraising, capital structure changes, and the final outcome of a financing activity. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV). Since it is a detailed announcement of the financing outcome, it is classified as CAP rather than the general fallback (RNS).
2018-06-01 English
KARO PHARMAS FÖRETRÄDESEMISSION FULLTECKNAD
Share Issue/Capital Change Classification · 99% confidence The document is a press release announcing that a rights issue ('företrädesemission') for Karo Pharma AB is fully subscribed ('fulltecknad'). It details the number of shares subscribed, the capital raised (approx. 1,315 MSEK), and the resulting changes in share capital and total number of shares. It also provides timelines for registration and trading of the new shares. This content directly relates to fundraising, financing activities, and capital structure changes. Based on the definitions: - It is not an Annual Report (10-K). - It is not a standard Earnings Release (ER), as it focuses on the financing event, not operational results. - It is not a Dividend Notice (DIV). - It perfectly matches the description for 'Capital/Financing Update' (Code: CAP), which covers company fundraising and capital structure changes.
2018-06-01 Swedish
KARO PHARMA OFFENTLIGGÖR TILLÄGGSPROSPEKT
Report Publication Announcement Classification · 98% confidence The document is a press release from Karo Pharma AB announcing the publication and approval of a 'Tilläggsprospekt' (Supplemental Prospectus) related to a rights issue ('företrädesemission'). It explicitly states that the prospectus is now available on company and bank websites and details the right for investors to withdraw previous subscription commitments following the supplement. This structure—announcing the availability of a key offering document (the prospectus) via a short press release—fits the definition of a Report Publication Announcement (RPA). Although it relates to a financing activity (CAP), the document itself is the announcement of the publication of the prospectus, not the prospectus or the financing details themselves. Given the document length (4551 chars) and its primary function being to state that the prospectus 'har nu godkänts och registrerats' and is 'tillgängligt', RPA is the most appropriate classification based on Rule 2 (The 'MENU VS MEAL' Rule).
2018-05-23 Swedish
KARO PHARMA PUBLISHES PROSPECTUS SUPPLEMENT
Report Publication Announcement Classification · 98% confidence The document is a press release titled "KARO PHARMA PUBLISHES PROSPECTUS SUPPLEMENT". It explicitly states that the company has prepared a prospectus supplement which has been approved and registered by the Swedish Financial Supervisory Authority, and it directs readers to where this document (the prospectus supplement) can be found (company website, SEB's website, Swedbank's website). The document itself is short (under 5,000 characters) and its primary function is to announce the publication and availability of a formal offering document (the prospectus supplement) and detail the rights of investors to withdraw previous applications. This fits the definition of a Report Publication Announcement (RPA), as it announces the release of another document rather than being the comprehensive report itself.
2018-05-23 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.